HeartMate® family of left ventricular assist systems

Icenogle TB , Smith RG , Cleavinger M et al. Thromboembolic complications of the symbion AVAD system . Int J Artif Organs 1989; 13: 532-538 .

Didisheim P , Olsen DB , Farrar DJ et al. Infection and thromboembolism with implantable cardiovascular devices . Trans Am Soc Artif Intern Organs 1989; 35: 54-70 .

Levinson MM , Smith RG , Cork RC et al. Thromboembolic complications of the Jarvik-7 total artificial heart: case report . Int J Artif Organs 1986; 10: 236-244 .

Waagner WR , Johnson PC , Kormos RL et al. Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients . Circulation 1993; 88: 2023-2029 .

Schmid C , Weyland M , Nabavi DG et al. Cerebal and systemic embolization during left ventricular support with the Novacor N100 device . Ann Thorac Surg 1988; 65: 1703-1710 .

Kaplan KL , Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo . Blood 1981; 57: 199-202 .

Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 . Nature 1970: 227: 680-685 .

Lazarides E , Hubbard BD. Immunological characterization of the subunit of the 100 A filaments from muscle cells . Proc Natl Acad Sci USA 1976; 73: 4344-4348 .

Rose EA , Levin HR , Oz MC et al. Artificial circulatory support with textured interior surfaces: a counter-intuitive approach to minimize thromboembolism . Circulation 1994; 90(Suppl. II): 87-II-91 .

Oz MC , Argenziano M , Catanesek KA et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation 1997; 95: 1844-1852 .

Graham TR , Argenziano M , Catanesek A et al. Neointimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device . Eur J Cardiothoracic Surg 1990; 4: 182-190 .

Frazier OH , Rose EA , Macmanus Q et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device . Ann Thorac Surg 1992; 53: 1080-1090 .

Oz MC , Goldstein DJ , Pepino P et al. Sreening scale predicts patients successfully receiving long-term implantable left ventricular assist devices . Circulation 1995; 92: II-169-II-173 .

Gracin N , Johnson MR , Spokas D et al. The use of APACHE II scores to select candidates for left ventricular assist device placement . J Heart Lung Transplant 1998; 17: 1017-1023 .

Poirier V. The economic burden of artificial hearts. In: Nose I , KjellStrand C , Ivanovich P eds. Progress in artificial organs. Cleveland, OH: ISAO Press 1986: 96-99.

Kormos RL , Gasior TA , Kawai A et al. Transplant candidate’s clinical status rather than right ventricular function defines need for univentricular versus biventricular support J Thorac Cardiovasc Surg 1996; 111: 773-783 .

Cryer HG , Mavroudis C , Yo J et al. Shock, transfusion, and pneumonectomy. Death is due to right heart failure and increased pulmonary vascular resistance . Ann Surg 1990; 212: 197-201 .

Goldstein DJ , Seldomridge JA , Chen JM et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use and perioperative mortality . Ann Thorac Surg 1995; 59: 1063-1068 .

Kaplon RJ , Gillinov AM , Smedira NG et al. Vitamin K reduces bleeding in left ventricular assist device recipients . J Heart Lung Transplant 1999; 18: 346-350 .

McCarthy PM. Matching the patient to the operation. Satellite Symposium: What’s New in Cardiac Assist and Recovery? Eighteenth Annual Meeting and Scientific Sessions, International Society for Heart and Lung Transplantation April 15, 1998, Chicago, IL.

Macdonald PS , Kedgh A , Mundy J et al. Adjunctive use of inhaled nitric oxide during implantation of a left ventricular assist device . J Heart Lung Transplant 1998; 17: 312-316 .

Argenziano M , Choudhri AF , Moazami N et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipeints with pulmonary hypertension . Ann Thoracic Surg 1998; 65: 340-345 .

Goldstein DJ , Oz MC , Rose EA. Implantable left ventricular assist devices . N Engl J Med 1998; 339: 1522-1533 .

Moskowitz AJ , Weinberg AD , Oz MC , Williams DL. Quality of life with an implanted left ventricular assist device . Ann Thorac Surg 1997: 64: 1764-1769 .

Churchill DN , Torrance GW , Taylor DW et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach . Clin Invest Med 1987; 10: 14-20 .

Bombardier C , Ware J , Russell IJ , Larson M , Chalmers A , Read JL. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial . Am J Med 1986; 81: 565-578 .